MFS Total Return Fund C (MTRCX - Free Report) seeks to to provide above-average income consistent with the prudent employment of capital. Its secondary objective is to provide reasonable opportunity for growth of capital and income. MTRCX is a ''balanced fund,'' and invests in a combination of equity and fixed income securities. Under normal market conditions, the fund invests, at least 40%, but not more than 75%, of its net assets in equity securities, and at least 25% of its net assets in non-convertible fixed income securities. The fund may vary the percentage of its assets invested in any one type of security (within the limits described above) in accordance with the fund manager's interpretation of economic and money market conditions, fiscal and monetary policy, and underlying security values. MTRCX's investments may include securities traded on securities exchanges or in the over-the-counter markets. The fund may invest in foreign securities, and may have exposure to foreign currencies through its investment in these securities.
This Allocation Balanced product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 5.6% and 5 year 8%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
MTRCX’s performance, as of the last filing, when compared to funds in its category was in the top 54% over the past 1 year, and in the top 29% over the past 3 years and in the top 34% over the past 5 years.
The MFS Total Return Fund C, as of the last filing, allocates its fund in top three groups; Large Value, Intermediate Bond and Large Growth. Further, as of the last filing, Jpmorgan Chase & Co, Philip Morris Internation and Johnson & Johnson were the top holdings for MTRCX.
This Zacks Rank #2 (Buy) was incepted in October 1970 and is managed by MFS. MTRCX carries an expense ratio of 1.49% and requires a minimal initial investment of $1,000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>